Association between response to anti-PD-1 treatment and blood soluble PD-L1 and IL-8 changes in patients with NSCLC

In this study, we explored the dynamic changes in blood sPD-L1 and its clinical value during anti-PD-1 immunotherapy in non-small cell lung cancer (NSCLC) patients. First, we established a sandwich ELISA for functional sPD-L1 that can bind to PD-1 and has biological functions. By monitoring function...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Ling, Wang, Xiaojue, Fu, Siyun, Yan, Zhuohong, Ma, Tianyu, Li, Siqi, Wei, Panjian, Zhang, Hongtao, Wang, Jinghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060455/
https://www.ncbi.nlm.nih.gov/pubmed/36991160
http://dx.doi.org/10.1007/s12672-023-00641-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060455/
https://www.ncbi.nlm.nih.gov/pubmed/36991160
http://dx.doi.org/10.1007/s12672-023-00641-2

Ejemplares similares